OLANZAPINE (OLANZAPINE) — FDA Approval ANDA210022 (CADILA PHARMS LTD)
OLANZAPINE (OLANZAPINE) — FDA Approval ANDA210022 (CADILA PHARMS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OLANZAPINE; Active ingredients: OLANZAPINE; Application number: ANDA210022.
| Brand name | OLANZAPINE |
|---|---|
| Active ingredients | OLANZAPINE |
| Application number | ANDA210022 |
| Sponsor | CADILA PHARMS LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 6 |
| First approval date | 20230224 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →